These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240 [TBL] [Abstract][Full Text] [Related]
4. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. O'Brien TD; Butler PC; Westermark P; Johnson KH Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454 [TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients. Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232 [TBL] [Abstract][Full Text] [Related]
7. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Jaikaran ET; Clark A Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221 [TBL] [Abstract][Full Text] [Related]
8. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus. Jeong HR; An SS Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727 [TBL] [Abstract][Full Text] [Related]
10. No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes. Ahrén B; Gutniak M Eur J Endocrinol; 1997 Dec; 137(6):643-9. PubMed ID: 9437230 [TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects. Tomita T Islets; 2012; 4(3):223-32. PubMed ID: 22847497 [TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide (IAPP). A short review. Stridsberg M; Wilander E Acta Oncol; 1991; 30(4):451-6. PubMed ID: 1854502 [TBL] [Abstract][Full Text] [Related]
13. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831 [TBL] [Abstract][Full Text] [Related]
14. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes? Johnson KH; O'Brien TD; Westermark P Diabetes; 1991 Mar; 40(3):310-4. PubMed ID: 1999270 [TBL] [Abstract][Full Text] [Related]
15. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance. MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722 [TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. Matveyenko AV; Butler PC ILAR J; 2006; 47(3):225-33. PubMed ID: 16804197 [TBL] [Abstract][Full Text] [Related]
17. Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats. Mulder H; Ahrén B; Sundler F J Endocrinol; 1997 Mar; 152(3):495-501. PubMed ID: 9071971 [TBL] [Abstract][Full Text] [Related]
18. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry. Gorus FK; Sodoyez JC; Pipeleers DG; Keymeulen B; Foriers A; Van Schravendijk CF Diabetologia; 1992 Nov; 35(11):1080-6. PubMed ID: 1473619 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism. Valdermarsson S; Leckström A; Westermark P; Bergenfelz A Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529 [TBL] [Abstract][Full Text] [Related]
20. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Kahn SE; Andrikopoulos S; Verchere CB Diabetes; 1999 Feb; 48(2):241-53. PubMed ID: 10334297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]